Home › Funds › M. Kulyk & Associates, LLC › LH

M. Kulyk & Associates, LLC position in LH

LABCORP HOLDINGS INC · Health Care

M. Kulyk & Associates, LLC reported holding 23,846 shares of LH (LABCORP HOLDINGS INC) in its Q3 2026 13F filing — a position valued at US$7.3M, representing 1.23% of its reported portfolio and ranking #30 among its reported holdings. M. Kulyk & Associates, LLC has disclosed LH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)23.85K sh
Reported value held$7.35M
Portfolio Weight1.23%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How M. Kulyk & Associates, LLC's LH position evolved

M. Kulyk & Associates, LLC first disclosed a stake in LH in Q3 2023 at 17,722 shares (US$3.6M). The position peaked in Q3 2026 at 23,846 shares, worth US$7.3M. Across 13 filings, M. Kulyk & Associates, LLC increased the stake 8 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 23,846 shares valued at US$7.3M — a reduction of -267 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 17.72K $3.56M New
Q4 2023 18.76K $4.26M Add
Q1 2024 20.30K $4.43M Add
Q2 2024 23.16K $4.71M Add
Q3 2024 23.23K $5.19M Hold
Q4 2024 22.31K $5.12M Reduce
Q1 2025 19.68K $4.58M Reduce
Q2 2025 19.99K $5.25M Add
Q3 2025 21.28K $6.11M Add
Q4 2025 22.56K $5.66M Add
Q1 2026 23.25K $6.20M Add
Q2 2026 24.11K $6.75M Add
Q3 2026 23.85K $7.35M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LH and 13F data

LH (LABCORP HOLDINGS INC) is a Health Care company. 27 other funds we track also report a position in LH — the largest reported positions include VICTORY CAPITAL MANAGEMENT INC (US$1.21B), Boston Partners (US$908.7M), Allspring Global Investments Holdings, LLC (US$632.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LH

All LH fund holders →

FAQ

How long has M. Kulyk & Associates, LLC held LH?

M. Kulyk & Associates, LLC has disclosed LH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is M. Kulyk & Associates, LLC's current position in LH?

As of Q3 2026, M. Kulyk & Associates, LLC holds 23.85K shares of LH (LABCORP HOLDINGS INC), valued at $7.35M, representing 1.23% of its reported portfolio and ranking #30.

Has M. Kulyk & Associates, LLC been buying or selling LH?

In the latest 13F filing (Q3 2026), M. Kulyk & Associates, LLC reduced its position in LH. The position peaked in Q3 2026 at 23.85K shares.

Which other funds hold LH?

Other major institutional holders of LH include VICTORY CAPITAL MANAGEMENT INC, Boston Partners, Allspring Global Investments Holdings, LLC, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.